<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[DM3Loc: multi-label mRNA subcellular localization prediction and analysis based on multi-head self-attention mechanism]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073021048-b54e7c18-f08e-4bff-a129-dacfa4e6d118/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab016</link>
            <description><![CDATA[<p class="para" id="N65541">Subcellular localization of messenger RNAs (mRNAs), as a prevalent mechanism, gives precise and efficient control for the translation process. There is mounting evidence for the important roles of this process in a variety of cellular events. Computational methods for mRNA subcellular localization prediction provide a useful approach for studying mRNA functions. However, few computational methods were designed for mRNA subcellular localization prediction and their performance have room for improvement. Especially, there is still no available tool to predict for mRNAs that have multiple localization annotations. In this paper, we propose a multi-head self-attention method, DM3Loc, for multi-label mRNA subcellular localization prediction. Evaluation results show that DM3Loc outperforms existing methods and tools in general. Furthermore, DM3Loc has the interpretation ability to analyze RNA-binding protein motifs and key signals on mRNAs for subcellular localization. Our analyses found hundreds of instances of mRNA isoform-specific subcellular localizations and many significantly enriched gene functions for mRNAs in different subcellular localizations.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Single cell epigenetic visualization assay]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072818409-0606c8a3-b73f-44c5-89bc-92d20b3446c6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab009</link>
            <description><![CDATA[<p class="para" id="N65541">Characterization of the epigenetic status of individual cells remains a challenge. Current sequencing approaches have limited coverage, and it is difficult to assign an epigenetic status to the transcription state of individual gene alleles in the same cell. To address these limitations, a targeted microscopy-based epigenetic visualization assay (EVA) was developed for detection and quantification of epigenetic marks at genes of interest in single cells. The assay is based on an <i>in situ</i> biochemical reaction between an antibody-conjugated alkaline phosphatase bound to the epigenetic mark of interest, and a 5′-phosphorylated fluorophore-labeled DNA oligo tethered to a target gene by gene-specific oligonucleotides. When the epigenetic mark is present at the gene, phosphate group removal by the phosphatase protects the oligo from λ-exonuclease activity providing a quantitative fluorescent readout. We applied EVA to measure 5-methylcytosine (5mC) and H3K9Ac levels at different genes and the HIV-1 provirus in human cell lines. To link epigenetic marks to gene transcription, EVA was combined with RNA-FISH. Higher 5mC levels at the silenced compared to transcribed <i>XIST</i> gene alleles in female somatic cells validated this approach and demonstrated that EVA can be used to relate epigenetic marks to the transcription status of individual gene alleles.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766072818409-0606c8a3-b73f-44c5-89bc-92d20b3446c6/assets/gkab009gra1.jpg" alt="Epigenetic mark visualization at a gene of interest. Alkaline phosphatase (AP) is recruited to the epigenetic mark (purple) as an antibody conjugate. Gene specific oligonucleotides anchor phosphorylated sensor oligo (red) annealed to a detector oligo (green). When the epigenetic mark is present at the gene, the AP-dephosphorylated oligo survives subsequent λ-exonuclease treatment. The presence of the epigenetic mark at the gene is quantitated using the ratio of detector/sensor signal intensities (green/red)."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Epigenetic mark visualization at a gene of interest. Alkaline phosphatase (AP) is recruited to the epigenetic mark (purple) as an antibody conjugate. Gene specific oligonucleotides anchor phosphorylated sensor oligo (red) annealed to a detector oligo (green). When the epigenetic mark is present at the gene, the AP-dephosphorylated oligo survives subsequent λ-exonuclease treatment. The presence of the epigenetic mark at the gene is quantitated using the ratio of detector/sensor signal intensities (green/red).</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural parameters of palindromic repeats determine the specificity of nuclease attack of secondary structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036740470-d7611695-8624-4c9a-be8f-85412c847583/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab168</link>
            <description><![CDATA[<p class="para" id="N65541">Palindromic sequences are a potent source of chromosomal instability in many organisms and are implicated in the pathogenesis of human diseases. In this study, we investigate which nucleases are responsible for cleavage of the hairpin and cruciform structures and generation of double-strand breaks at inverted repeats in <i>Saccharomyces cerevisiae</i>. We demonstrate that the involvement of structure-specific nucleases in palindrome fragility depends on the distance between inverted repeats and their transcriptional status. The attack by the Mre11 complex is constrained to hairpins with loops &lt;9 nucleotides. This restriction is alleviated upon RPA depletion, indicating that RPA controls the stability and/or formation of secondary structures otherwise responsible for replication fork stalling and DSB formation. Mus81-Mms4 cleavage of cruciforms occurs at divergently but not convergently transcribed or nontranscribed repeats. Our study also reveals the third pathway for fragility at perfect and quasi-palindromes, which involves cruciform resolution during the G2 phase of the cell cycle.</p>]]></description>
            <pubDate><![CDATA[2021-03-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[High-resolution visualization and quantification of nucleic acid–based therapeutics in cells and tissues using Nanoscale secondary ion mass spectrometry (NanoSIMS)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762231584-c700bf2d-0cc1-42af-a1eb-7741f33d4976/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1112</link>
            <description><![CDATA[<p class="para" id="N65541">Nucleic acid therapeutics (NATs) have proven useful in promoting the degradation of specific transcripts, modifying gene expression, and regulating mRNA splicing. In each situation, efficient delivery of nucleic acids to cells, tissues and intracellular compartments is crucial—both for optimizing efficacy and reducing side effects. Despite successes in NATs, our understanding of their cellular uptake and distribution in tissues is limited. Current methods have yielded insights into distribution of NATs within cells and tissues, but the sensitivity and resolution of these approaches are limited. Here, we show that nanoscale secondary ion mass spectrometry (NanoSIMS) imaging can be used to define the distribution of 5-bromo-2′-deoxythymidine (5-BrdT) modified antisense oligonucleotides (ASO) in cells and tissues with high sensitivity and spatial resolution. This approach makes it possible to define ASO uptake and distribution in different subcellular compartments and to quantify the impact of targeting ligands designed to promote ASO uptake by cells. Our studies showed that phosphorothioate ASOs are associated with filopodia and the inner nuclear membrane in cultured cells, and also revealed substantial cellular and subcellular heterogeneity of ASO uptake in mouse tissues. NanoSIMS imaging represents a significant advance in visualizing uptake and distribution of NATs; this approach will be useful in optimizing efficacy and delivery of NATs for treating human disease.</p>]]></description>
            <pubDate><![CDATA[2020-12-04T00:00]]></pubDate>
        </item>
    </channel>
</rss>